未登录Resibufogenin and Oxaliplatin Synergistically Inhibit Diffuse Gastric Cancer by Inactivating the FAK/AKT/GSK3β/β-Catenin Signaling PathwayResibufogenin和奥沙利铂通过失活FAK/AKT/GSK3β/β-catenin信号通路协同抑制弥漫性胃癌
Hu, Hui-Hui; Shang, Hai-Li; Ren, Yongjing; Lv, Hui-Fang; Tu, Shuiping; Wang, Jian-Zheng; Gong, Ya-Nan; Li, Zhi-Fei; Zhang, He; Li, Tiepeng; Wang, Yuhang; Chen, Bei-Bei; Wang, Sai-Qi; Chen, Xiao-Bing .png)
分享.png)
收藏Single-arm, open-label, multicentre phase 1b/2 study to evaluate the safety and efficacy of fruquintinib combined with sintilimab and CAPEOX as a first-line treatment for advanced gastric or gastroesophageal junction adenocarcinoma (FUNCTION study): a study protocol单臂、开放标签、多中心Ib/II期研究，旨在评估 fruquintinib 联合 sintilimab 和 CAPEOX 作为晚期胃或胃食管结合部腺癌一线治疗的 safety 和 efficacy（FUNCTION 研究）：一项研究方案Chen, Beibei; Zhao, Jing; Lv, Huifang; Xu, Weifeng; Wang, Jianzheng; Nie, Caiyun; He, Yunduan; Zhang, Bin; Huang, Jinxi; Liu, Yingjun; Ma, Fei; Zhang, He; Guo, Lanwei; Liu, Yudong; Li, Peng; Chen, Xiaofeng; Chen, Xiaobing 分享 收藏 分享 收藏 In era of immunotherapy: the value of trastuzumab beyond progression in patients with trastuzumab-resistant HER2-positive advanced or metastatic gastric cancerWang, Hui; Nie, Caiyun; Xu, Weifeng; Li, Jing; Gou, He; Lv, Huifang; Chen, Beibei; Wang, Jianzheng; Liu, Yingjun; He, Yunduan; Zhao, Jing; Chen, Xiaobing 分享 收藏 分享 收藏 Immune checkpoint inhibitors enhanced the antitumor efficacy of disitamab vedotin for patients with HER2-positive or HER2-low advanced or metastatic gastric cancer: a multicenter real-world studyNie, Caiyun; Xu, Weifeng; Guo, Yanwei; Gao, Xiaohui; Lv, Huifang; Chen, Beibei; Wang, Jianzheng; Liu, Yingjun; Zhao, Jing; Wang, Saiqi; He, Yunduan; Chen, Xiaobing 分享 收藏 An Exploration of Trifluridine/Tipiracil Monotherapy and in Combination With Bevacizumab or Immune Checkpoint Inhibitors for Patients With Metastatic Colorectal Cancer: A Real-World StudyNie, Caiyun; Xu, Weifeng; Chen, Beibei; Lv, Huifang; Wang, Jianzheng; Liu, Yingjun; He, Yunduan; Wang, Saiqi; Zhao, Jing; Chen, Xiaobing 分享 收藏 Efficacy of regorafenib combined with PD-1 inhibitors in elderly patients with advanced metastatic colorectal cancerChen, Beibei; Zhao, Huichen; Huang, Jinxi; Lv, Huifang; Xu, Weifeng; Nie, Caiyun; Wang, Jianzheng; Zhao, Jing; He, Yunduan; Wang, Saiqi; Chen, Xiaobing 分享 收藏 分享 收藏 分享 收藏 Microsatellite stable metastatic colorectal cancer without liver metastasis may be preferred population for regorafenib or fruquintinib plus sintilimab as third-line or above therapy:A real-world studyNie, Caiyun; Lv, Huifang; Chen, Beibei; Xu, Weifeng; Wang, Jianzheng; Liu, Yingjun; Wang, Saiqi; Zhao, Jing; He, Yunduan; Chen, Xiaobing 分享 收藏 Preclinical studies of the triazolo[1,5-a]pyrimidine derivative WS-716 as a highly potent, specific and orally active P-glycoprotein (P-gp) inhibitorWang, Sai-Qi; Teng, Qiu-Xu; Wang, Shuai; Lei, Zi-Ning; Hu, Hui-Hui; Lv, Hui-Fang; Chen, Bei-Bei; Wang, Jian-Zheng; Shi, Xiao-Jing; Xu, Wei-Feng; Liu, Hong-Min; Chen, Xiao-Bing; Chen, Zhe-Sheng; Yu, Bin 分享 收藏 Clinical Study of Anlotinib as Third-Line or Above Therapy in Patients With Advanced or Metastatic Gastric Cancer: A Multicenter Retrospective StudyNie, Caiyun; He, Yunduan; Lv, Huifang; Gao, Ming; Gao, Xiaohui; Chen, Beibei; Xu, Weifeng; Wang, Jianzheng; Liu, Yingjun; Zhao, Jing; Chen, Xiaobing 分享 收藏 The Efficacy and Safety of Sintilimab Combined With Nab-Paclitaxel as a Second-Line Treatment for Advanced or Metastatic Gastric Cancer and Gastroesophageal Junction CancerWang, Jianzheng; He, Yunduan; Zhang, Baiwen; Lv, Huifang; Nie, Caiyun; Chen, Beibei; Xu, Weifeng; Zhao, Jing; Cheng, Xiaojiao; Li, Qingli; Tu, Shuiping; Chen, Xiaobing 分享 收藏 分享 收藏 Combination of Anlotinib and Celecoxib for the Treatment of Abdominal Desmoid Tumor: A Case Report and Literature ReviewWang, Jianzheng; Li, Hongle; Wang, Hui; Li, Qingli; Bai, Xuanye; Lv, Huifang; Nie, Caiyun; Chen, Beibei; Xu, Weifeng; Tu, Shuiping; Chen, Xiaobing 分享 收藏 分享 收藏 Overview on the Role of E-Cadherin in Gastric Cancer: Dysregulation and Clinical ImplicationsZhao, Huichen; Hu, Huihui; Chen, Beibei; Xu, Weifeng; Zhao, Jing; Huang, Chen; Xing, Yishu; Lv, Huifang; Nie, Caiyun; Wang, Jianzheng; He, Yunduan; Wang, Sai-Qi; Chen, Xiao-Bing 分享 收藏 A PD-1 Inhibitor Induces Complete Response of Advanced Bladder Urothelial Carcinoma: A Case ReportWang, Jianzheng; Li, Qingli; Lv, Huifang; Nie, Caiyun; Chen, Beibei; Xu, Weifeng; Yang, Tiejun; Zhang, Yinping; Tu, Shuiping; Chen, Xiaobing 分享 收藏 Expression of Human Epidermal Growth Factor Receptor-2 Status and Programmed Cell Death Protein-1 Ligand Is Associated With Prognosis in Gastric Cancer (vol 10, 580045, 2021)Lv, Huifang; Zhang, Junling; Sun, Keran; Nie, Caiyun; Chen, Beibei; Wang, Jianzheng; Xu, Weifeng; Wang, Saiqi; Liu, Yingjun; Chen, Xiaobing 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png)
BMJ OPEN.png)
